2 of the best investment trusts to buy now

These investment trusts have some unique qualities that help them stand head and shoulders above the competition, says this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Elevated view over city of London skyline

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I have allocated a percentage of my portfolio to investment trusts.  This is because I believe these vehicles are one of the best ways for me to build exposure to different sectors and industries. If I am not comfortable investing in an industry, I would rather outsource the process. 

Unique investment trusts 

A great example is the Allianz Technology Trust (LSE: ATT), which I would add to my portfolio to build exposure to the global technology sector.

Over the past five years, the trust has returned more than 300%, thanks to its exposure to high growth technology stocks such as Microsoft

Past performance should never be used to guide future potential and I think it is unlikely the trust will repeat this impressive performance over the next five years.

Nevertheless, as a way to build exposure to corporations like Microsoft and other more niche operators such as the cloud security company Zscaler, I think the trust looks incredibly attractive. 

Unfortunately, some investment trusts can be quite expensive ways to invest in the market. Most charge an annual portfolio management fee, and some even charge a performance fee if they exceed their benchmark return.

The Allianz Technology Trust charges both. These fees exceeded 3.6% in 2020, although the trust did return 80% compared to its benchmark return of 42%. In the long run, these high fees could eat into investor returns. 

Still, I am willing to pay a fee to investment trust managers who have experience in a particular sector. That is why I would buy this trust for my portfolio today despite the high cost. 

Healthcare sector champion 

Another trust I already own and would buy more of for my portfolio is the Worldwide Healthcare Trust (LSE: WWH).

This trust charges an annual management fee of just under 1%. It is managed by a team of experienced medical professionals who provide unique insight into the global healthcare sector. I am willing to pay for this experience, especially in such a specialist industry. 

As well as paying a performance fee, another downside is that I have no input over the investments chosen. This is both a good and a bad thing. I can outsource the investment decisions to those who know better, but it also means that if they pick the wrong investments, my hard-earned money is at stake. 

Despite this risk, I own the healthcare trust in my portfolio to build exposure to the sector and buy into the experience of its management team. Some of the top holdings in the portfolio include American pharmaceutical and healthcare giants such as Boston Scientific. This unique company manufactures devices for the international medical market. 

The portfolio also contains several speculative names, such as Mirati Therapeutics which is developing cancer therapies. These high-risk, high-reward opportunities are not the sort of businesses I would be comfortable buying myself. I am happy to let the management team at this investment trust take on the work. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Rupert Hargreaves owns Worldwide Healthcare Trust plc. The Motley Fool UK has recommended Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smart young brown businesswoman working from home on a laptop
Investing Articles

Should I be watching the Greatland Gold (LSE: GGP) share price?

Recent rallies in valuable metal prices has boosted the Greatland Gold share price, but is there still an opportunity for…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

The abrdn share price is down 23% in the last year, should I buy?

Asset management firms have had a rough time lately, but with the abrdn share price down heavily, is now the…

Read more »

Hand of a mature man opening a safety deposit box.
Investing Articles

If I’d invested £5k in red hot BAE Systems shares 5 years ago here’s what I’d have today

BAE Systems shares have smashed the FTSE 100 for years and Harvey Jones is keen to buy more as they…

Read more »

Investing Articles

How I’d aim to earn £16,100 in passive income a year by investing £20k in a Stocks and Shares ISA

Harvey Jones is building a portfolio of high-yielding FTSE 100 dividend stocks that should give him a high and rising…

Read more »

Investing Articles

Down 8% in a month! The BP share price is screaming ‘buy, buy, buy’ at me right now 

When crude oil falls, the BP share price invariably follows. Harvey Jones is wondering whether this is the right point…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

Could the 9.8% M&G dividend yield get even bigger?

Christopher Ruane reckons that, although the M&G dividend yield is already close to a double-digit percentage, it could get better…

Read more »

Investing Articles

How much passive income could I earn by putting £380 a month into a Stocks and Shares ISA?

Christopher Ruane explains how he'd aim to turn a Stocks and Shares ISA into four-figure passive income streams each year.

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 passive income stocks I’m buying before an interest rate cut

With the market expecting interest rates to fall in August, time might be running out for investors looking to buy…

Read more »